Medical treatment of cholesterol gallstones by bile desaturating agents.
D002114:Calcinosis / Q000209:etiology; D002635:Chenodeoxycholic Acid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000175:diagnosis / Q000188:drug therapy*; D002784:Cholesterol / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D004338:Drug Combinations; D006801:Humans; D008099:Liver / Q000187:drug effects; D012008:Recurrence; D012995:Solubility; D013655:Taurochenodeoxycholic Acid / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D004338:Drug Combinations; D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D013655:Taurochenodeoxycholic Acid; C031655:ursodoxicoltaurine; D014580:Ursodeoxycholic Acid; D002784:Cholesterol